Global BCG Vaccine Market Research Report 2023

Publisher Name :
Date: 07-Jan-2023
No. of pages: 87
Inquire Before Buying

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.

Highlights

The global BCG Vaccine market was valued at US$ 373.7 million in 2022 and is anticipated to reach US$ 549.7 million by 2029, witnessing a CAGR of 5.6% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for BCG Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Vaccine.

The BCG Vaccine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global BCG Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the BCG Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Merck

- Sanofi Pasteur

- Japan BCG Lab

- China National Biotec

- Serum Institute of India

- Intervax

- GSBPL

Segment by Type

- Immune BCG

- Therapy BCG

Segment by Application

- Hospitals

- Clinics

- Others

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of BCG Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global BCG Vaccine Market Research Report 2023

Table of Contents
1 Cardiac Rhythm Management (CRM) Devices Market Overview
1.1 Product Overview and Scope of Cardiac Rhythm Management (CRM) Devices
1.2 Cardiac Rhythm Management (CRM) Devices Segment by Type
1.2.1 Global Cardiac Rhythm Management (CRM) Devices Market Value Comparison by Type (2023-2029)
1.2.2 Pacemaker
1.2.3 ICD
1.2.4 CRT
1.3 Cardiac Rhythm Management (CRM) Devices Segment by Application
1.3.1 Global Cardiac Rhythm Management (CRM) Devices Market Value by Application: (2023-2029)
1.3.2 Bradycardia
1.3.3 Tachycardia
1.3.4 Heart Failure
1.3.5 Others
1.4 Global Cardiac Rhythm Management (CRM) Devices Market Size Estimates and Forecasts
1.4.1 Global Cardiac Rhythm Management (CRM) Devices Revenue 2018-2029
1.4.2 Global Cardiac Rhythm Management (CRM) Devices Sales 2018-2029
1.4.3 Global Cardiac Rhythm Management (CRM) Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Cardiac Rhythm Management (CRM) Devices Market Competition by Manufacturers
2.1 Global Cardiac Rhythm Management (CRM) Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cardiac Rhythm Management (CRM) Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cardiac Rhythm Management (CRM) Devices Average Price by Manufacturers (2018-2023)
2.4 Global Cardiac Rhythm Management (CRM) Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cardiac Rhythm Management (CRM) Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiac Rhythm Management (CRM) Devices, Product Type & Application
2.7 Cardiac Rhythm Management (CRM) Devices Market Competitive Situation and Trends
2.7.1 Cardiac Rhythm Management (CRM) Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cardiac Rhythm Management (CRM) Devices Players Market Share by Revenue
2.7.3 Global Cardiac Rhythm Management (CRM) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cardiac Rhythm Management (CRM) Devices Retrospective Market Scenario by Region
3.1 Global Cardiac Rhythm Management (CRM) Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Cardiac Rhythm Management (CRM) Devices Global Cardiac Rhythm Management (CRM) Devices Sales by Region: 2018-2029
3.2.1 Global Cardiac Rhythm Management (CRM) Devices Sales by Region: 2018-2023
3.2.2 Global Cardiac Rhythm Management (CRM) Devices Sales by Region: 2024-2029
3.3 Global Cardiac Rhythm Management (CRM) Devices Global Cardiac Rhythm Management (CRM) Devices Revenue by Region: 2018-2029
3.3.1 Global Cardiac Rhythm Management (CRM) Devices Revenue by Region: 2018-2023
3.3.2 Global Cardiac Rhythm Management (CRM) Devices Revenue by Region: 2024-2029
3.4 North America Cardiac Rhythm Management (CRM) Devices Market Facts & Figures by Country
3.4.1 North America Cardiac Rhythm Management (CRM) Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Cardiac Rhythm Management (CRM) Devices Sales by Country (2018-2029)
3.4.3 North America Cardiac Rhythm Management (CRM) Devices Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cardiac Rhythm Management (CRM) Devices Market Facts & Figures by Country
3.5.1 Europe Cardiac Rhythm Management (CRM) Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Cardiac Rhythm Management (CRM) Devices Sales by Country (2018-2029)
3.5.3 Europe Cardiac Rhythm Management (CRM) Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiac Rhythm Management (CRM) Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Cardiac Rhythm Management (CRM) Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Cardiac Rhythm Management (CRM) Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Cardiac Rhythm Management (CRM) Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cardiac Rhythm Management (CRM) Devices Market Facts & Figures by Country
3.7.1 Latin America Cardiac Rhythm Management (CRM) Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Cardiac Rhythm Management (CRM) Devices Sales by Country (2018-2029)
3.7.3 Latin America Cardiac Rhythm Management (CRM) Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiac Rhythm Management (CRM) Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiac Rhythm Management (CRM) Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Cardiac Rhythm Management (CRM) Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Cardiac Rhythm Management (CRM) Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cardiac Rhythm Management (CRM) Devices Sales by Type (2018-2029)
4.1.1 Global Cardiac Rhythm Management (CRM) Devices Sales by Type (2018-2023)
4.1.2 Global Cardiac Rhythm Management (CRM) Devices Sales by Type (2024-2029)
4.1.3 Global Cardiac Rhythm Management (CRM) Devices Sales Market Share by Type (2018-2029)
4.2 Global Cardiac Rhythm Management (CRM) Devices Revenue by Type (2018-2029)
4.2.1 Global Cardiac Rhythm Management (CRM) Devices Revenue by Type (2018-2023)
4.2.2 Global Cardiac Rhythm Management (CRM) Devices Revenue by Type (2024-2029)
4.2.3 Global Cardiac Rhythm Management (CRM) Devices Revenue Market Share by Type (2018-2029)
4.3 Global Cardiac Rhythm Management (CRM) Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Cardiac Rhythm Management (CRM) Devices Sales by Application (2018-2029)
5.1.1 Global Cardiac Rhythm Management (CRM) Devices Sales by Application (2018-2023)
5.1.2 Global Cardiac Rhythm Management (CRM) Devices Sales by Application (2024-2029)
5.1.3 Global Cardiac Rhythm Management (CRM) Devices Sales Market Share by Application (2018-2029)
5.2 Global Cardiac Rhythm Management (CRM) Devices Revenue by Application (2018-2029)
5.2.1 Global Cardiac Rhythm Management (CRM) Devices Revenue by Application (2018-2023)
5.2.2 Global Cardiac Rhythm Management (CRM) Devices Revenue by Application (2024-2029)
5.2.3 Global Cardiac Rhythm Management (CRM) Devices Revenue Market Share by Application (2018-2029)
5.3 Global Cardiac Rhythm Management (CRM) Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Cardiac Rhythm Management (CRM) Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Cardiac Rhythm Management (CRM) Devices Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Cardiac Rhythm Management (CRM) Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Cardiac Rhythm Management (CRM) Devices Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Cardiac Rhythm Management (CRM) Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boston Scientific Cardiac Rhythm Management (CRM) Devices Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 Biotronik
6.4.1 Biotronik Corporation Information
6.4.2 Biotronik Description and Business Overview
6.4.3 Biotronik Cardiac Rhythm Management (CRM) Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biotronik Cardiac Rhythm Management (CRM) Devices Product Portfolio
6.4.5 Biotronik Recent Developments/Updates
6.5 LivaNova (Sorin)
6.5.1 LivaNova (Sorin) Corporation Information
6.5.2 LivaNova (Sorin) Description and Business Overview
6.5.3 LivaNova (Sorin) Cardiac Rhythm Management (CRM) Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 LivaNova (Sorin) Cardiac Rhythm Management (CRM) Devices Product Portfolio
6.5.5 LivaNova (Sorin) Recent Developments/Updates
6.6 Medico
6.6.1 Medico Corporation Information
6.6.2 Medico Description and Business Overview
6.6.3 Medico Cardiac Rhythm Management (CRM) Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Medico Cardiac Rhythm Management (CRM) Devices Product Portfolio
6.6.5 Medico Recent Developments/Updates
6.7 Lepu (Qinming Medical)
6.6.1 Lepu (Qinming Medical) Corporation Information
6.6.2 Lepu (Qinming Medical) Description and Business Overview
6.6.3 Lepu (Qinming Medical) Cardiac Rhythm Management (CRM) Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lepu (Qinming Medical) Cardiac Rhythm Management (CRM) Devices Product Portfolio
6.7.5 Lepu (Qinming Medical) Recent Developments/Updates
6.8 IMZ
6.8.1 IMZ Corporation Information
6.8.2 IMZ Description and Business Overview
6.8.3 IMZ Cardiac Rhythm Management (CRM) Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 IMZ Cardiac Rhythm Management (CRM) Devices Product Portfolio
6.8.5 IMZ Recent Developments/Updates
6.9 Cardioelectronica
6.9.1 Cardioelectronica Corporation Information
6.9.2 Cardioelectronica Description and Business Overview
6.9.3 Cardioelectronica Cardiac Rhythm Management (CRM) Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cardioelectronica Cardiac Rhythm Management (CRM) Devices Product Portfolio
6.9.5 Cardioelectronica Recent Developments/Updates
6.10 Pacetronix
6.10.1 Pacetronix Corporation Information
6.10.2 Pacetronix Description and Business Overview
6.10.3 Pacetronix Cardiac Rhythm Management (CRM) Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pacetronix Cardiac Rhythm Management (CRM) Devices Product Portfolio
6.10.5 Pacetronix Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiac Rhythm Management (CRM) Devices Industry Chain Analysis
7.2 Cardiac Rhythm Management (CRM) Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiac Rhythm Management (CRM) Devices Production Mode & Process
7.4 Cardiac Rhythm Management (CRM) Devices Sales and Marketing
7.4.1 Cardiac Rhythm Management (CRM) Devices Sales Channels
7.4.2 Cardiac Rhythm Management (CRM) Devices Distributors
7.5 Cardiac Rhythm Management (CRM) Devices Customers
8 Cardiac Rhythm Management (CRM) Devices Market Dynamics
8.1 Cardiac Rhythm Management (CRM) Devices Industry Trends
8.2 Cardiac Rhythm Management (CRM) Devices Market Drivers
8.3 Cardiac Rhythm Management (CRM) Devices Market Challenges
8.4 Cardiac Rhythm Management (CRM) Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global BCG Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global BCG Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global BCG Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global BCG Vaccine Sales (MT) of Key Manufacturers (2018-2023)
Table 5. Global BCG Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global BCG Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global BCG Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market BCG Vaccine Average Price (USD/Kg) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of BCG Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of BCG Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of BCG Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of BCG Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global BCG Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global BCG Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global BCG Vaccine Sales by Region (2018-2023) & (MT)
Table 18. Global BCG Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global BCG Vaccine Sales by Region (2024-2029) & (MT)
Table 20. Global BCG Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global BCG Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global BCG Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global BCG Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global BCG Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America BCG Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America BCG Vaccine Sales by Country (2018-2023) & (MT)
Table 27. North America BCG Vaccine Sales by Country (2024-2029) & (MT)
Table 28. North America BCG Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America BCG Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe BCG Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe BCG Vaccine Sales by Country (2018-2023) & (MT)
Table 32. Europe BCG Vaccine Sales by Country (2024-2029) & (MT)
Table 33. Europe BCG Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe BCG Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific BCG Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific BCG Vaccine Sales by Region (2018-2023) & (MT)
Table 37. Asia Pacific BCG Vaccine Sales by Region (2024-2029) & (MT)
Table 38. Asia Pacific BCG Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific BCG Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America BCG Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America BCG Vaccine Sales by Country (2018-2023) & (MT)
Table 42. Latin America BCG Vaccine Sales by Country (2024-2029) & (MT)
Table 43. Latin America BCG Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America BCG Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa BCG Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa BCG Vaccine Sales by Country (2018-2023) & (MT)
Table 47. Middle East & Africa BCG Vaccine Sales by Country (2024-2029) & (MT)
Table 48. Middle East & Africa BCG Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa BCG Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global BCG Vaccine Sales (MT) by Type (2018-2023)
Table 51. Global BCG Vaccine Sales (MT) by Type (2024-2029)
Table 52. Global BCG Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global BCG Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global BCG Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global BCG Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global BCG Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global BCG Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global BCG Vaccine Price (USD/Kg) by Type (2018-2023)
Table 59. Global BCG Vaccine Price (USD/Kg) by Type (2024-2029)
Table 60. Global BCG Vaccine Sales (MT) by Application (2018-2023)
Table 61. Global BCG Vaccine Sales (MT) by Application (2024-2029)
Table 62. Global BCG Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global BCG Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global BCG Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global BCG Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global BCG Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global BCG Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global BCG Vaccine Price (USD/Kg) by Application (2018-2023)
Table 69. Global BCG Vaccine Price (USD/Kg) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 73. Merck BCG Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 78. Sanofi Pasteur BCG Vaccine Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. Japan BCG Lab Corporation Information
Table 81. Japan BCG Lab Description and Business Overview
Table 82. Japan BCG Lab BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 83. Japan BCG Lab BCG Vaccine Product
Table 84. Japan BCG Lab Recent Developments/Updates
Table 85. China National Biotec Corporation Information
Table 86. China National Biotec Description and Business Overview
Table 87. China National Biotec BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 88. China National Biotec BCG Vaccine Product
Table 89. China National Biotec Recent Developments/Updates
Table 90. Serum Institute of India Corporation Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 93. Serum Institute of India BCG Vaccine Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. Intervax Corporation Information
Table 96. Intervax Description and Business Overview
Table 97. Intervax BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 98. Intervax BCG Vaccine Product
Table 99. Intervax Recent Developments/Updates
Table 100. GSBPL Corporation Information
Table 101. GSBPL Description and Business Overview
Table 102. GSBPL BCG Vaccine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 103. GSBPL BCG Vaccine Product
Table 104. GSBPL Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. BCG Vaccine Distributors List
Table 108. BCG Vaccine Customers List
Table 109. BCG Vaccine Market Trends
Table 110. BCG Vaccine Market Drivers
Table 111. BCG Vaccine Market Challenges
Table 112. BCG Vaccine Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of BCG Vaccine
Figure 2. Global BCG Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global BCG Vaccine Market Share by Type in 2022 & 2029
Figure 4. Immune BCG Product Picture
Figure 5. Therapy BCG Product Picture
Figure 6. Global BCG Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global BCG Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global BCG Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global BCG Vaccine Market Size (2018-2029) & (US$ Million)
Figure 13. Global BCG Vaccine Sales (2018-2029) & (MT)
Figure 14. Global BCG Vaccine Average Price (USD/Kg) & (2018-2029)
Figure 15. BCG Vaccine Report Years Considered
Figure 16. BCG Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global BCG Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest BCG Vaccine Players: Market Share by Revenue in 2022
Figure 19. BCG Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global BCG Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America BCG Vaccine Sales Market Share by Country (2018-2029)
Figure 22. North America BCG Vaccine Revenue Market Share by Country (2018-2029)
Figure 23. U.S. BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe BCG Vaccine Sales Market Share by Country (2018-2029)
Figure 26. Europe BCG Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. Germany BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific BCG Vaccine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific BCG Vaccine Revenue Market Share by Region (2018-2029)
Figure 34. China BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America BCG Vaccine Sales Market Share by Country (2018-2029)
Figure 45. Latin America BCG Vaccine Revenue Market Share by Country (2018-2029)
Figure 46. Mexico BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa BCG Vaccine Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa BCG Vaccine Revenue Market Share by Country (2018-2029)
Figure 51. Turkey BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E BCG Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of BCG Vaccine by Type (2018-2029)
Figure 55. Global Revenue Market Share of BCG Vaccine by Type (2018-2029)
Figure 56. Global BCG Vaccine Price (USD/Kg) by Type (2018-2029)
Figure 57. Global Sales Market Share of BCG Vaccine by Application (2018-2029)
Figure 58. Global Revenue Market Share of BCG Vaccine by Application (2018-2029)
Figure 59. Global BCG Vaccine Price (USD/Kg) by Application (2018-2029)
Figure 60. BCG Vaccine Value Chain
Figure 61. BCG Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global BCG Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Peptide Cancer Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......
  • Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......
  • Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......
  • Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105
    Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......
  • Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110
    Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......
  • Global BCG Vaccine Market Research Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135
    BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
  • Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105
    BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
  • Infectious Vaccine Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300
    Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs